Covered recipient · General Payments record
JEFFREY L CUMMINGS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$936,244.16
- Reported across 530 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $69,252.40 | 28 |
| Honoraria | $8,775.00 | 1 |
| Travel and Lodging | $7,668.33 | 7 |
| Food and Beverage | $1,500.19 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $16,975.70 | 7 |
| F. Hoffmann-La Roche AG | $12,999.63 | 7 |
| EISAI INC. | $12,671.90 | 17 |
| Novo Nordisk AS | $8,855.17 | 4 |
| H. Lundbeck A S | $8,775.00 | 1 |
| Eli Lilly and Company | $6,250.00 | 4 |
| E.R. Squibb & Sons, L.L.C. | $4,550.00 | 2 |
| Lilly USA, LLC | $4,350.00 | 1 |
| ABBVIE INC. | $4,016.06 | 9 |
| Shionogi Inc | $3,425.00 | 2 |
| Merck Sharp & Dohme Corporation | $2,557.50 | 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,189.96 | 2 |
| Ipsen Bioscience Inc | $580.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (61)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $600.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133349 | CMS |
| ABBVIE INC. | $800.00 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103133351 | CMS |
| ABBVIE INC. | $50.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521648 | CMS |
| ABBVIE INC. | $50.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521650 | CMS |
| ABBVIE INC. | $25.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521652 | CMS |
| ABBVIE INC. | $25.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521654 | CMS |
| ABBVIE INC. | $2,070.06 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182370 | CMS |
| ABBVIE INC. | $198.00 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182372 | CMS |
| ABBVIE INC. | $198.00 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104182374 | CMS |
| Biogen, Inc. | $613.00 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104856656 | CMS |
| Biogen, Inc. | $459.75 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104846408 | CMS |
| Biogen, Inc. | $17.67 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104830144 | CMS |
| Biogen, Inc. | $28.13 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104853320 | CMS |
| Biogen, Inc. | $4,452.50 | 08/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104825526 | CMS |
| Biogen, Inc. | $613.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104833457 | CMS |
| Biogen, Inc. | $10,791.65 | 09/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104867056 | CMS |
| E.R. Squibb & Sons, L.L.C. | $3,250.00 | 08/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101782187 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,300.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101782276 | CMS |
| Eisai Inc. | $25.00 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751728 | CMS |
| Eisai Inc. | $40.26 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751730 | CMS |
| Eisai Inc. | $26.12 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751732 | CMS |
| Eisai Inc. | $15.23 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751734 | CMS |
| Eisai Inc. | $3,510.00 | 03/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751722 | CMS |
| Eisai Inc. | $4,680.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751702 | CMS |
| Eisai Inc. | $35.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751704 | CMS |
| Eisai Inc. | $50.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751706 | CMS |
| Eisai Inc. | $125.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751708 | CMS |
| Eisai Inc. | $10.84 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751710 | CMS |
| Eisai Inc. | $64.96 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751712 | CMS |
| Eisai Inc. | $23.61 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751714 | CMS |
| Eisai Inc. | $121.78 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751716 | CMS |
| Eisai Inc. | $68.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751718 | CMS |
| Eisai Inc. | $52.19 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110751720 | CMS |
| Eisai Inc. | $3,510.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110751724 | CMS |
| Eisai Inc. | $313.57 | 10/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110751726 | CMS |
| Eli Lilly and Company | $35.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135010489 | CMS |
| Eli Lilly and Company | $140.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135037335 | CMS |
| Eli Lilly and Company | $3,900.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135054270 | CMS |
| Eli Lilly and Company | $2,175.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135054274 | CMS |
| F. Hoffmann-La Roche AG | $1,380.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133029267 | CMS |
| F. Hoffmann-La Roche AG | $280.16 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133029271 | CMS |
| F. Hoffmann-La Roche AG | $5,175.00 | 07/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133029275 | CMS |
| F. Hoffmann-La Roche AG | $4,485.00 | 09/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133029279 | CMS |
| F. Hoffmann-La Roche AG | $1,380.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133029284 | CMS |
| F. Hoffmann-La Roche AG | $228.88 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133029287 | CMS |
| F. Hoffmann-La Roche AG | $70.59 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133029291 | CMS |
| H. Lundbeck A S | $8,775.00 | 12/31/2024 | Honoraria | Undisputed | 01/23/2026 | 1145885591 | CMS |
| Ipsen Bioscience Inc. | $580.00 | 03/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1067524412 | CMS |
| Lilly USA, LLC | $4,350.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135054272 | CMS |
| Merck Sharp & Dohme LLC | $465.00 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141708626 | CMS |
| Merck Sharp & Dohme LLC | $1,162.50 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141708628 | CMS |
| Merck Sharp & Dohme LLC | $465.00 | 07/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141708610 | CMS |
| Merck Sharp & Dohme LLC | $465.00 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141708612 | CMS |
| Novo Nordisk AS | $112.58 | 11/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552121 | CMS |
| Novo Nordisk AS | $4,547.24 | 11/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552827 | CMS |
| Novo Nordisk AS | $70.35 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096553057 | CMS |
| Novo Nordisk AS | $4,125.00 | 11/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096553261 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,140.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118836219 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $49.96 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118836221 | CMS |
| Shionogi Inc | $1,232.00 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154659842 | CMS |
| Shionogi Inc | $2,193.00 | 09/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1154659844 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.